Evaluation of respiratory function (obstruction and air entrapment);Evaluación funcional respiratoria (obstrucción y atrapamiento)

Archivos de Bronconeumologia

Volumn 43, Issue SUPPL. 3, 2007, Pages 8-14

  García Río, Francisco ^a,b   Lores, Vanesa ^a   Rojo, Blas ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b Alfredo Marquerie   (Spain)

Author keywords

Air entrapment; Airflow limitation; COPD; Hyperinflation; Pulmonary volumes; Spirometry

Indexed keywords

AIRWAY OBSTRUCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DYSPNEA; EVALUATION; EXERCISE TOLERANCE; FORCED EXPIRATORY VOLUME; HUMAN; INSPIRATORY CAPACITY; LUNG ALVEOLUS; LUNG FLOW VOLUME CURVE; LUNG PARENCHYMA; LUNG VOLUME; REPRODUCIBILITY; RESPIRATORY FUNCTION; REVIEW; SPIROMETRY;

EID: 38349182453     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/S0300-2896(07)71180-8     Document Type: Article

References (27)

1. American Thoracic Society. Standardization of spirometry. 1994 update. Am J Respir Crit Care Med. 1995;152:1107-36.
2. Niewoehner DE. Structure-function relationships: the pathophysiology of airflow obstruction. En: Stockley R, Rennard S, Rabe K, Celli B, editors. Chronic obstructive pulmonary disease. Massachusetts: Blackwell Publishing Ltd.; 2007. p. 3-19.
3. Corne S, Anthonisen NR. Lung-function testing in chronic obstructive pulmonary disease. En: Stockley R, Rennard S, Rabe K, Celli B, editors. Chronic obstructive pulmonary disease. Massachusetts: Blackwell Publishing Ltd.; 2007. p. 256-69.
4. Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med. 1968;278:1355-60.
5. Macklen PT. Mechanical factors determinig maximun broncho-constriction. Eur Respir J. 1989; 2 Suppl 6:516S-19S.
6. Pride NB. Test of forced expiration and inspiration. Clin Chest Med. 2001;22:599-622.
7. O'Donnell DE. Assessment of bronchodilatador efficacy in symptomatic COPD. Is spirometry useful? Chest. 2000;117:42S-7S.
8. Celli BR, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932-46.
9. Pauwels RA, Butist AS, Calverley PMA, Jenkins SR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Iniciative for the chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med. 2001;163:1256-76.
10. Zieliñski J, Bednarek M. Early detection of COPD in a high-risk population using spirometric screening. Chest. 2001;119:731-6.
11. Burrows B, Earle KH. Course and prognosis of chronic obstructive lung disease. N Engl J Med. 1969;280:397-404.
12. Fletcher CM, Peto R. The natural history of chronic airflow obstruction. Br Med J. 1978;1:1645-8.
13. Anthonisen NR, Wright EC, IPPB trial group. Bronchodilator response in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1986;134:814-9.
14. O'Donnell DE, Lam MIU, Webb KA. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160:542-9.
15. O'Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164;770-7.
16. Gelb AF, Willians AJ, Zamel N. Spirometry: FEV1vs FEF25-75 percent. Chest. 1983;84:473-4.
17. Berend N, Nelson NA, Rutland J, Marlin GE, Woolcock AJ. The maximum expiratory flow-volume curve with air and a low-density gas misture. An analysis of subject and observer variability. Chest. 1981;80:23-30.
18. Melissinos CG, Webster P, Tien YK, et al. Time dependence of maximal flow as an index of nonuniform emptying. J Appl Physiol. 1979;47:1043-50.
19. Calverley PMA, Koulouris NG. Flow limitation and dynamic hyperinflation: key concepts in modern respiratory physiology. Eur Respir J. 2005;25:186-99.
20. Koulouris NG, Valta P, Lavoie A, Corbeil C, Chassé M, Braidy J, et al. A simple method to detect expiratory flow limitation during spontaneous breathing. Eur Respir J. 1995;8:306-313
21. Eltayara L, Becklake M, Volta C, Milic-Emili J. Relationship between chronic dyspnea and expiratory flow limitation in patients with COPD. Am J Respir Crit Care Med. 1996;154:1726-34.
22. Marini JJ. Should PEEP be used in airflow obstruction. Am Rev Respir Dis. 1989;140:1-3.
23. Ferguson GT. Why does the lung hyperinflation? Proc Am Thorac Soc. 2006;3:176-9.
24. Leith DE, Brown R. Human lung volumes and the mechanisms that set them. Eur Respir J. 1999;13:468-72.
25. Gibson GJ. Pulmonary hyperinflation a clinical overview. Eur Respir J. 1996;9:2640-9.
26. O'Donnell DE. Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2006;3:180-4.
27. Cooper CB. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. Am J Med. 2006;119:S21-S31.